Skip to content

Released May 1, 2024, after the close

10-Q filed May 2, 2024, 32 days after period end · 0001653477-24-000058

Q1 2024 · 10-Q
Revenue$340.10M−13.4% vs Q1 2023no prior Q4 2023 on file
Net Income-$56.00MN/M vs Q1 2023N/M vs Q4 2023
EPS Diluted-$1.54N/M vs Q1 2023no prior Q4 2023 on file
Gross Profit$99,700,000−23.5%
Operating Income$76,900,000−26.0%
Operating Cash Flow-$12,100,000N/M
Free Cash Flowderived-$28,700,000N/M
Margins · derived
Gross margin29.3%−3.9 pt vs Q1 2023
Operating margin22.6%−3.9 pt vs Q1 2023
Net margin-16.5%−29.4 pt vs Q1 2023

What the release said

The release

Same quarter

MetricQ1 2024Q1 2023Q1 2022Q1 2021
Revenue$340.10M$392.60M$382.80M$320.30M
Net Income-$56.00M$50.70M$60.80M$48.70M
EPS Diluted-$1.54$1.35$1.55$1.20

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR